Enhancement of electronic conductivity of LiAl0.3Co0.7O2via Mg dopingC. Li; X. Xu; C. Wang; Y. Xu; W. Xu; G. Chen · 2003

Impacts of Ti on electrical properties ofH. X. Xu; J. P. Xu; C. X. Li; C. L. Chan; P. T. Lai · 2010

Oxidation of Ag–Sn–Sb alloy powdersC. P. Wu; D. Q. Yi; S. Goto; C. H. Xu; W. Weng; J. M. Zhou; G. F. Xu · 2012

Polar metabolite of cholesterol induces rat cognitive dysfunctionsS. Zhao; W. Liao; N. Xu; H. Xu; C. Yu; X. Liu; C. Li · 2009

Study on ionic Rydberg states of calciumC. B. Xu; X. P. Xie; R. C. Zhao; W. Sun; P. Xue; Z. P. Zhong; W. Huang; X. Y. Xu · 1998

Low temperature magnetic measurements of NENPO. Avenel; J. Xu; J. S. Xia; M-F. Xu; B. Andraka; T. Lang; P. L. Moyland; W. Ni; P. J. C. Signore; C. M. C. M. Woerkens; E. D. Adams; G. G. Ihas; M. W. Meisel; S. E. Nagler; N. S. Sullivan; Y. Takano; D. R. Talham; T. Goto; N. Fujiwara · 1992

probed by Ti dopingHooper, J.; Fang, M. H.; Zhou, M.; Fobes, D.; Dang, N.; Mao, Z. Q.; Feng, C. M.; Xu, Z. A.; Yu, M. H.; O’Connor, C. J.; Xu, G. J.; Andersen, N.; Salamon, M. · Physical Review B · 2007

The orbital symmetry of carbon monoxide on a Cs-precovered Ru(1010) surfaceH. Y. Li; S. Bao; B. Xu; C. Y. Xu; C. Y. Fan; P. M. He; Y. B. Xu; F. Q. Liu; K. Yibulaxin; H. J. Qian; Y. H. Dong · 1998

Platinum neurotoxicity pharmacogeneticsMcWhinney, S. R.; Goldberg, R. M.; McLeod, H. L. · Molecular Cancer Therapeutics · 2009

The Discovery of Lapatinib (GW572016)Rusnak, D.; Gilmer, T. M. · Molecular Cancer Therapeutics · 2011

Therapeutic value of glycosaminoglycans in cancerYip, G. W. · Molecular Cancer Therapeutics · 2006

The Patient Impact FactorMolecular Cancer Therapeutics · 2011

The role of neuropilins in cancerEllis, L. M. · Molecular Cancer Therapeutics · 2006

Curcumin sensitizes multiple myeloma to chemotherapyMolecular Cancer Therapeutics · 2009

Studies in target-based treatmentKurzrock, R. · Molecular Cancer Therapeutics · 2007

Aurora kinase inhibitorMolecular Cancer Therapeutics · 2006